Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors inside the central nervous procedure, conolidine modulates alternate molecular targets. A Science Advancements study discovered that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXC… Read More